Results 111 to 120 of about 15,641 (133)

Therapy-Related Myeloid Neoplasms After [¹⁷⁷Lu]Lu-PSMA Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Series

Journal of Nuclear Medicine
[177Lu]Lu-prostate-specific membrane antigen (PSMA) therapy has a favorable toxicity profile in patients with metastatic castration-resistant prostate cancer (mCRPC). Therapy-related myeloid neoplasm (t-MN) has been described after [177Lu]Lu-DOTATATE but has not, to our knowledge, yet been reported after [177Lu]Lu-PSMA.
Michal, Eifer, Duncan E K, Sutherland, Isaac, Goncalves, James P, Buteau, Lewis, Au, Arun A, Azad, Louise, Emmett, Grace, Kong, Louise, Kostos, Aravind S, Ravi Kumar, Edmond M, Kwan, Elizabeth, Medhurst, Shahneen, Sandhu, Ben, Tran, Alexander W, Wyatt, Michael S, Hofman   +15 more
openaire   +2 more sources

Distinct Response to Platinum-Based Chemotherapy among Patients with Metastatic Castration-Resistant Prostate Cancer Harboring Alterations in Genes Involved in Homologous Recombination

Journal of Urology, 2021
Yinjie Zhu, Jianjun Sha, Yanqing Wang
exaly  

Indirect Comparison of Darolutamide versus Apalutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer

Journal of Urology, 2021
Susan Halabi, Emi Terasawa, Rajeev Ayyagari   +2 more
exaly  

Descriptive study on burden and communication of fatigue among castration-resistant prostate cancer patients in Japan

Current Medical Research and Opinion, 2022
Taro Iguchi, Yusuke Nakamura, Eric Yu
exaly  

Studies on Prostatic Cancer: I. The Effect of Castration, Of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate

Ca-A Cancer Journal for Clinicians, 1972
Charles Huggins
exaly  

Clinical development of novel therapeutics for castration‐resistant prostate cancer

Ca-A Cancer Journal for Clinicians, 2012
Matthew D Galsky, Alexander C Small, Che-Kai Tsao   +2 more
exaly  

Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2018

Journal of Urology, 2018
William T Lowrance, William K Oh, David F Jarrard   +2 more
exaly  

Neuroendocrine differentiation of prostatic adenocarcinoma – an important cause for castration-resistant disease recurrence

Journal of Laboratory Medicine, 2019
João Lobo
exaly